ArticleFrontiers in cell and developmental biology2021

BRAF Mutation as a Potential Therapeutic Target for Checkpoint Inhibitors: A Comprehensive Analysis of Immune Microenvironment in BRAF Mutated Colon Cancer.

Shuyi Cen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.